These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16953628)

  • 1. Phage display affords peptides that modulate beta-amyloid aggregation.
    Orner BP; Liu L; Murphy RM; Kiessling LL
    J Am Chem Soc; 2006 Sep; 128(36):11882-9. PubMed ID: 16953628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
    Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
    J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
    Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
    Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects.
    Sun X; Wu WH; Liu Q; Chen MS; Yu YP; Ma Y; Zhao YF; Li YM
    Peptides; 2009 Jul; 30(7):1282-7. PubMed ID: 19397942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
    Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding and membrane insertion of amyloid-beta (25-35) peptide and its mutants: implications for aggregation and neurotoxicity.
    Tsai HH; Lee JB; Tseng SS; Pan XA; Shih YC
    Proteins; 2010 Jun; 78(8):1909-25. PubMed ID: 20229606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
    Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
    Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of inhibition of beta-amyloid aggregation by transthyretin.
    Liu L; Murphy RM
    Biochemistry; 2006 Dec; 45(51):15702-9. PubMed ID: 17176092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
    Gibson TJ; Murphy RM
    Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J; Siegel SJ; Fu Y; Kelly JW
    Biochemistry; 2008 Jan; 47(1):50-9. PubMed ID: 18078350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of amyloid beta fragments in aqueous environments.
    Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
    FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
    Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
    Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
    Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
    Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.